Mesenchymal stem cell therapy in Parkinson's disease animal models
A. Gugliandolo et al, 2017, Current Research in Translational Medicine CrossRef
Therapy With Mesenchymal Stem Cells in Parkinson Disease
Daniel Mendes Filho et al, 2018, The Neurologist CrossRef
β-asarone increases MEF2D and TH levels and reduces α-synuclein level in 6-OHDA-induced rats via regulating the HSP70/MAPK/MEF2D/Beclin-1 pathway: Chaperone-mediated autophagy activation, macroautophagy inhibition and HSP70 up-expression
Liping Huang et al, 2016, Behavioural Brain Research CrossRef
How does conserved dopamine neurotrophic factor protect against and rescue neurodegeneration of PC12 cells?
Chao-shi Niu et al, 2017, Neural Regeneration Research CrossRef
Mesenchymal Stem Cells for Neurological Disorders
Anna Andrzejewska et al, 2021, Advanced Science CrossRef
Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson’s Disease
Tingting Tang et al, 2017, Neuroscience Bulletin CrossRef
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
Nathan P. Staff et al, 2019, Mayo Clinic Proceedings CrossRef
Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson’s disease
Dominika Fričová et al, 2020, npj Regenerative Medicine CrossRef
Strategies to Improve the Quality and Freshness of Human Bone Marrow-Derived Mesenchymal Stem Cells for Neurological Diseases
Da Yeon Lee et al, 2021, Stem Cells International CrossRef
Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism
Päivi Lindholm et al, 2022, Molecular Psychiatry CrossRef
Mesenchymal stem cells as a multimodal treatment for nervous system diseases
Bogna Badyra et al, 2020, Stem Cells Translational Medicine CrossRef
Modulating Microglia/Macrophage Activation by CDNF Promotes Transplantation of Fetal Ventral Mesencephalic Graft Survival and Function in a Hemiparkinsonian Rat Model
Kuan-Yin Tseng et al, 2022, Biomedicines CrossRef